Abeona Therapeutics Inc (ABEO)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc ... - PR Newswire

PR Newswire

Abeona Therapeutics (NASDAQ:ABEO) Price Target Cut to $21.00 by Analysts at Cantor Fitzgerald - MarketBeat

MarketBeat

Abeona Therapeutics' (NASDAQ:ABEO) Shareholders Are Down 85% On Their Shares - Yahoo Sport Australia

Yahoo Sport Australia

Is Abeona Therapeutics (ABEO) Outperforming Other Medical Stocks This Year? - Yahoo Movies UK

Yahoo Movies UK

Abeona Therapeutics bolsters finances as it seeks FDA approval for a key treatment - Crain's Cleveland Business

Crain's Cleveland Business

Abeona Therapeutics: Q1 Earnings Snapshot | Region | dailyindependent.com - The Independent

The Independent

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress - GlobeNewswire

GlobeNewswire

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress

GlobeNewswire Inc.

Abeona Therapeutics Inc (NASDAQ:ABEO) Sees Significant Increase in Short Interest - MarketBeat

MarketBeat

Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Up 62.6% in April - Defense World

Defense World

Abeona Therapeutics to Present at Jefferies Gene Editing & Gene Therapy Summit - Yahoo News UK

Yahoo News UK

Abeona Therapeutics (NASDAQ:ABEO) Stock Passes Below Fifty Day Moving Average of $6.90 - MarketBeat

MarketBeat

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Canada Finance

Yahoo Canada Finance

Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below 50 Day Moving Average of $6.90 - Defense World

Defense World

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Canada Finance

Yahoo Canada Finance

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc ... - PR Newswire

PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc ... - PR Newswire

PR Newswire

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire Inc.

Public equity report: Soleno, Abeona raise capital for late-stage rare disease programs - BioCentury

BioCentury

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics ... - Business Wire

Business Wire

Buying The Dip In Abeona Therapeutics After The Recent Manufacturing-Related CRL (ABEO) - Seeking Alpha

Seeking Alpha

We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate - Simply Wall St

Simply Wall St

Abeona Therapeutics director acquires $24.7k in stock By Investing.com - Investing.com

Investing.com

Faith L. Charles Buys 7,550 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) Stock - MarketBeat

MarketBeat

Abeona Therapeutics Inc (NASDAQ:ABEO) SVP Brendan M. O'malley Purchases 8600 Shares - Defense World

Defense World

Abeona Therapeutics executive buys $27,864 in company stock By Investing.com - Investing.com Canada

Investing.com Canada

SHAREHOLDER ALERT: Abeona Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations ... - GlobeNewswire

GlobeNewswire

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Abeona Th - Benzinga

Benzinga

Abeona Therapeutics Provides Regulatory Update on Pz-cel

GlobeNewswire Inc.

FDA requests additional data from Abeona for RDEB therapy - Investing.com

Investing.com

(ABEO) Technical Pivots with Risk Controls - Stock Traders Daily

Stock Traders Daily

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Here's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation - Yahoo Finance

Yahoo Finance

Abeona Therapeutics Full Year 2023 Earnings: EPS Misses Expectations - Simply Wall St

Simply Wall St

Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results - GuruFocus.com

GuruFocus.com

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections

GlobeNewswire Inc.

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections - GlobeNewswire

GlobeNewswire

Why Abeona Therapeutics (ABEO) Could Be Positioned for a Slump - Yahoo Movies Canada

Yahoo Movies Canada

Several Insiders Invested In Abeona Therapeutics Flagging Positive News - Yahoo Finance

Yahoo Finance

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Hedge funds investors have a lot riding on Abeona Therapeutics Inc. (NASDAQ:ABEO) with 33% ownership - Simply Wall St

Simply Wall St

Steven Cohen's Firm Increases Stake in Abeona Therapeutics Inc - Yahoo Finance

Yahoo Finance

Thinking about buying stock in BioXcel Therapeutics, Hitek Global, Abeona Therapeutics, Mullen Automotive, or ... - Marketscreener.com

Marketscreener.com

Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

Benzinga

Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying - Abeona Therapeutics (NASDAQ:ABEO) - Benzinga

Benzinga

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)

GlobeNewswire Inc.

When Will Abeona Therapeutics Inc. (NASDAQ:ABEO) Become Profitable? - Simply Wall St

Simply Wall St

Abeona Therapeutics Inc. (NASDAQ:ABEO): When Will It Breakeven? - Yahoo Finance

Yahoo Finance

Abeona Therapeutics Announces $50 Million Credit Facility - GlobeNewswire

GlobeNewswire